- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
Suprane (desflurane) is an anesthetic drug used in the induction and maintenance of general anesthesia. It is a volatile liquid that is administered through inhalation. It is a fluorinated hydrocarbon that is rapidly metabolized in the body, making it a short-acting anesthetic. Suprane is known for its rapid onset and offset of action, making it a popular choice for short surgical procedures. It is also used in combination with other anesthetics to provide a balanced anesthetic effect.
Suprane is used in a variety of medical settings, including operating rooms, intensive care units, and emergency departments. It is also used in veterinary medicine. The drug is available in a variety of formulations, including a premixed solution and a vaporizer.
The Suprane market is highly competitive, with several major players. These include Baxter International, Hospira, and AbbVie. Other companies in the market include Merck, Teva Pharmaceuticals, and Mylan. Show Less Read more